Freddy A. Jimenez insider trades
Open-market stock purchases and sales by Freddy A. Jimenez, SVP & GENERAL COUNSEL at Celldex Therapeutics, Inc, from SEC Form 4 filings since Jun 17, 2021.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -19%.
Companies traded
- CLDX Celldex Therapeutics, Inc: 1 buy, 4 sales, last Jun 25, 2026